Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-02-07
2006-02-07
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C435S325000
Reexamination Certificate
active
06995011
ABSTRACT:
Disclosed is an expression control system with which any gene of interest can be transferred into mammalian cells to thereby change the nature thereof and the gene can be excised at any time by administering a low molecular weight compound to the cells. Specifically disclosed is a vector satisfying specific requirements when inserted into the genome of a mammalian cell.
REFERENCES:
patent: 5629159 (1997-05-01), Anderson
patent: 1 083 227 (2001-03-01), None
patent: 11-507230 (1999-06-01), None
patent: WO 96/40877 (1996-12-01), None
H. Niwa, Rengenerative Medicine and Life Science, vol. 45, No. 13, pp. 2047-2055 (2000) (with English abstract) “A mechanism for differentiation fate determination of ES cells”.
N. Nakatsuji, “Human multipotent stem cell lines . . . ”, Regenerative Medicine and Life Science, vol. 45, No. 13, pp. 2037-2046 (2000) (with Englsih abstract).
N. Nakauchi, “Analysis of purification and properties . . . ” Regenerative Medicine and Life Science, vol. 45, No. 13, pp. 2056-2062 (2000) (with English Abstract).
H. Okano, “Neural stem cells”, Regenerative Medicine and Life Science, vol. 45, No. 13, pp. 2063-2077 (2000) (with English Abstract).
K. Fukuda, “Differentiation from marrow-mesenchymal stem cells . . . ”, Regenerative Medicine and Life Science, vol. 45, No. 13, pp. 2078-2084 (2000) (with English Abstract).
D. L. Clarke et al., Science, vol. 288, pp. 1660-1663 (Jun. 2, 2000) “Generalized Potential of Adult Neural Stem Cells”.
N. Kobayashi et al., Science, vol. 287. pp. 1258-1262 (Feb. 18, 2000) “Prevention of acute liver failure in rats with reversibly immortalized human hepatpcytes”.
“Tetracylcine as Regulator of Inducible Gene Expression in Mammalian Cells”, Molecular Cloning, Third Ed., Cold Spring Harbor Laboratory Press, pp. 17.52-17.59 (2001).
M. Gossen et al., Proc. Natl. Acad. Sci. USA, vol. 89, pp. 5547-5551 (Jun. 1992) “Tight control of gene expression in mammalian cells by tetracycline-responsive prononters”.
M. Gossen et al., Science, vol. 268, pp. 1766-1769 (Jun. 23, 1995) “Transcriptional Activation by Tetracyclines in Mammalian Cells”.
S. R. Magari et al., J. Clin. Invest., vol. 100, No. 11, pp., 2865-2872 (Dec. 1997) “Pharmacologic control of humanized gene therapy system implanted into nude mice”.
T. Clackson, Curr. Opn. Chem. Biol., vol. 1, pp. 210-218 (1997) “Controlling mammalian gene expression with small molecules”.
D. M. Harvey et al., Opn. Chem. Biol., vol. 2, pp. 512-518 (1998) Inducible control of gene expression: prospects for gene therapy.
“Ecdysone as Regulator of Inducible Gene Expression in Mammalian Cells”, Molecular Cloning, Third Ed., Cold Spring Harbor Press, pp. 17.71-17.74 (2001).
E. Saez et a., PNAS, vol. 97, No. 26, pp. 14512-14517 (Dec. 19, 2000) Identification of ligands and coligands for the ecdysone-regulated gene switch.
D. No et al., Proc. Natl. Acad. Sci. USA, vol. 93, pp. 3346-3351 (Apr. 1996) “Ecdysone-inducible gene expression in mammalian cells and transgenic mice”.
M. Fussenegger et al., Nature Biotechnology, vol. 18, pp. 1203-1208 (Nov. 18, 2000) “Streptoggramin-based gene regulation systems for mammalian cells”.
U. Baron et al., Proc. Natl. Acad. Sci. USA, vol. 96, pp. 1013-1018 (Feb. 1999) Generation of conditional mutants in higher eukaryotes by switching between the expressions of two genes.
F. M. V. Rossi et al., Molecular Cell, vol. 6, pp. 723-728 (Sep. 2000) “Transcriptional COntrol: Rheustat Converted to on/off Switch”.
A. Hofmann et al., Proc. Natl. Acad. Sci. USA, vol. 93, pp. 5185-5190 (May 1996) “Rapid retoviral delivery of tetracyline inducible genes in a single autoregulatory cassette”.
C. Gorman et al., Curr. Opn. Biotech., vol. 11, pp. 455-460 (2000) “Site-specific gene targeting for gene expression in eukaryotes”.
F. Buchholz et al., Nature Biotechnology, vol. 16, pp. 657-662 (Jul. 16, 1998) “Improved properties of FLP recombinase evolved by cycling mutagenesis”.
B. Sauer, Curr. Opn. Biotech., vol. 5, pp. 521-527 (1994) “Site-specific recombination: developments and applications”.
D. Metzger et al., Curr. Opn. Biotech., vol. 10, pp. 470-476 (1999) “Engineering the mouse genone by site-specific recombination”.
K. A. Westerman et al., Proc. Natl. Acad. Sci. USA, vol. 93, pp. 8971-8976 (Aug. 1996) Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination.
E. Saez et al., Curr. Opn. Biotech., vol. 8, pp. 608-616 (1997) “Inducible gene expression in mammalian cells and transgenic mice”.
W. Paulus et al., J. Biotech., vol. 81, pp. 159-165 (2000) Variability of transcriptional regulation after gene transfer with the retroviral tetracycline system.
L. St-Onge et al., Nucleic Acids Research, vol. 24, No. 19, pp. 3875-3877 (1996) Temporal Control of the cre recombinase in transgenic mice by tetracycline responsive promoter.
“Tetracycline as Regulator of Inducible”, Molecular Cloning, Third Ed., Cold Spring Harbor Press, pp. 17.56-17.57 (2001) LpGene Expression in Mammalian Cells.
R. Pollock et al., PNAS, vol. 97, No. 24, pp. 13221-13226, (Nov. 21, 2000) “Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral nector”.
W. Paulus et al., J. Virol., vol. 70, No. 1, pp. 62-67 (Jan. 1996) Self-contained,tetracycline-regulated retroviral vector system for gene delivery to mammalian cells.
Hanazono Yutaka
Itoh Akira
Ozawa Keiya
Asahi Kasei Kabushiki Kaisha
Garvey Tara L.
Ketter James
LandOfFree
Vector for reversible gene integration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vector for reversible gene integration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vector for reversible gene integration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3703596